Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gaggi

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Bollettino Chimico Farmaceutico|May 1, 1975
Preliminary investigations on a new antiinflammatory steroid (Cortivazol)A M Gianni, R Gaggi
Japanese Journal of Pharmacology|May 1, 1991
Effects of brain biogenic amines of repeated treatments with calcium antagonistsR Gaggi, A M Gianni
Contributions to Nephrology|January 1, 1989
The natural history of reflux nephropathyP Zucchelli, R Gaggi, A Zuccalà
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Calcium channel blockers: effects on progressive renal diseaseP Zucchelli, A Zuccalà, R Gaggi
Behavioural Pharmacology|May 23, 2000
Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic functionR Dall'Olio, O Gandolfi, R Gaggi
Contributions to Nephrology|January 1, 1994
Primary hypertension as a cause of end-stage renal failureP Zucchelli, A Zuccalà, R Gaggi
Il Farmaco; Edizione Scientifica|February 1, 1982
[Beta-adrenolytic activity of naphtho(2,1-b)furan derivatives]R Gaggi, G Giovanninetti, L Garuti
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failureP Zucchelli, A Zuccalà, R Gaggi
Behavioural Pharmacology|February 24, 2001
D-Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic functionR Dall'Olio, O Gandolfi, R Gaggi
Contributions to Nephrology|January 1, 1992
Angiotensin converting enzyme inhibitors and calcium antagonists in the progression of renal insufficiencyP Zucchelli, R Gaggi, A Zuccalà
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Bollettino Chimico Farmaceutico|May 1, 1975
Preliminary investigations on a new antiinflammatory steroid (Cortivazol)A M Gianni, R Gaggi
Japanese Journal of Pharmacology|May 1, 1991
Effects of brain biogenic amines of repeated treatments with calcium antagonistsR Gaggi, A M Gianni
Contributions to Nephrology|January 1, 1989
The natural history of reflux nephropathyP Zucchelli, R Gaggi, A Zuccalà
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Calcium channel blockers: effects on progressive renal diseaseP Zucchelli, A Zuccalà, R Gaggi
Behavioural Pharmacology|May 23, 2000
Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic functionR Dall'Olio, O Gandolfi, R Gaggi
Contributions to Nephrology|January 1, 1994
Primary hypertension as a cause of end-stage renal failureP Zucchelli, A Zuccalà, R Gaggi
Il Farmaco; Edizione Scientifica|February 1, 1982
[Beta-adrenolytic activity of naphtho(2,1-b)furan derivatives]R Gaggi, G Giovanninetti, L Garuti
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failureP Zucchelli, A Zuccalà, R Gaggi
Behavioural Pharmacology|February 24, 2001
D-Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic functionR Dall'Olio, O Gandolfi, R Gaggi
Contributions to Nephrology|January 1, 1992
Angiotensin converting enzyme inhibitors and calcium antagonists in the progression of renal insufficiencyP Zucchelli, R Gaggi, A Zuccalà
Pageof 7